Barclays PLC Has $447,000 Stake in Ardent Health Partners, LLC (NYSE:ARDT)

Barclays PLC raised its stake in Ardent Health Partners, LLC (NYSE:ARDT) by 24.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 26,177 shares of the company’s stock after purchasing an additional 5,185 shares during the quarter. Barclays PLC’s holdings in Ardent Health Partners were worth $447,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently modified their holdings of the company. US Bancorp DE purchased a new stake in Ardent Health Partners in the 4th quarter valued at about $31,000. Bank of New York Mellon Corp lifted its holdings in Ardent Health Partners by 8.2% during the fourth quarter. Bank of New York Mellon Corp now owns 25,615 shares of the company’s stock worth $438,000 after acquiring an additional 1,941 shares during the period. Geode Capital Management LLC increased its position in shares of Ardent Health Partners by 1.5% during the 4th quarter. Geode Capital Management LLC now owns 142,563 shares of the company’s stock valued at $2,435,000 after purchasing an additional 2,127 shares during the last quarter. R Squared Ltd bought a new stake in shares of Ardent Health Partners during the 4th quarter worth $37,000. Finally, New York State Common Retirement Fund purchased a new position in shares of Ardent Health Partners in the 4th quarter worth about $48,000.

Ardent Health Partners Stock Performance

NYSE ARDT opened at $14.48 on Friday. The company’s 50 day simple moving average is $13.09 and its two-hundred day simple moving average is $14.97. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78. Ardent Health Partners, LLC has a 1 year low of $11.31 and a 1 year high of $20.72. The stock has a market capitalization of $2.07 billion and a PE ratio of 8.88.

Ardent Health Partners (NYSE:ARDT) last posted its quarterly earnings data on Tuesday, May 6th. The company reported $0.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.21 by $0.08. The business had revenue of $1.50 billion for the quarter, compared to the consensus estimate of $1.50 billion. Analysts predict that Ardent Health Partners, LLC will post 1.23 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on ARDT shares. Stephens reiterated an “overweight” rating and issued a $22.00 target price on shares of Ardent Health Partners in a research note on Tuesday, April 1st. Morgan Stanley decreased their target price on Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating for the company in a research report on Tuesday, January 21st. Guggenheim upped their price target on Ardent Health Partners from $16.00 to $18.00 and gave the company a “buy” rating in a research report on Friday. Royal Bank of Canada decreased their price objective on Ardent Health Partners from $23.00 to $21.00 and set an “outperform” rating for the company in a report on Tuesday, March 4th. Finally, Mizuho cut their target price on shares of Ardent Health Partners from $19.00 to $18.00 and set an “outperform” rating for the company in a research report on Wednesday, April 9th. Two equities research analysts have rated the stock with a hold rating, nine have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Buy” and a consensus target price of $20.75.

Ardent Health Partners Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.